Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122948008 | 12294800 | 8 | F | 201607 | 20160805 | 20160422 | 20160811 | PER | US-PFIZER INC-2016219587 | PFIZER | 57.00 | YR | F | Y | 45.81000 | KG | 20160811 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122948008 | 12294800 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | 50 MG, CYCLIC (28 DAYS ON/14 DAYS OFF) | N | 21938 | 50 | MG | CAPSULE, HARD | |||||||
| 122948008 | 12294800 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | 50 MG, CYCLIC (50 MG - 28 DAYS ON/14 DAYS OFF) | N | 21938 | 50 | MG | CAPSULE, HARD | |||||||
| 122948008 | 12294800 | 3 | SS | SUTENT | SUNITINIB MALATE | 1 | 37.5 MG, CYCLIC (2 WEEKS ON/1 WEEK OFF) | N | 21938 | 37.5 | MG | CAPSULE, HARD | |||||||
| 122948008 | 12294800 | 4 | SS | SUTENT | SUNITINIB MALATE | 1 | 57 MG, UNK | N | 21938 | 57 | MG | CAPSULE, HARD | |||||||
| 122948008 | 12294800 | 5 | SS | SUTENT | SUNITINIB MALATE | 1 | 37 MG, CYCLIC (2 WEEKS OFF AND 1 WEEK ON) | N | 21938 | 37 | MG | CAPSULE, HARD | |||||||
| 122948008 | 12294800 | 6 | SS | SUTENT | SUNITINIB MALATE | 1 | UNK | N | 258CA | 21938 | CAPSULE, HARD | ||||||||
| 122948008 | 12294800 | 7 | C | TYLENOL | ACETAMINOPHEN | 1 | UNK | 0 | |||||||||||
| 122948008 | 12294800 | 8 | C | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 122948008 | 12294800 | 9 | C | ALEVE | NAPROXEN SODIUM | 1 | UNK UNK, AS NEEDED | 0 | |||||||||||
| 122948008 | 12294800 | 10 | C | LISINOPRIL. | LISINOPRIL | 1 | UNK | 0 | |||||||||||
| 122948008 | 12294800 | 11 | C | FENTANYL. | FENTANYL | 1 | 1 DF, AS NEEDED (ONE PATCH FOR THREE DAYS) | 0 | 1 | DF | TRANSDERMAL PATCH |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122948008 | 12294800 | 1 | Metastatic renal cell carcinoma |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122948008 | 12294800 | Constipation | |
| 122948008 | 12294800 | Dyspnoea | |
| 122948008 | 12294800 | Gingival bleeding | |
| 122948008 | 12294800 | Gingival pain | |
| 122948008 | 12294800 | Hypertension | |
| 122948008 | 12294800 | Oral mucosal blistering | |
| 122948008 | 12294800 | Platelet count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122948008 | 12294800 | 1 | 20160321 | 20160608 | 0 | |
| 122948008 | 12294800 | 2 | 20160503 | 20160608 | 0 | |
| 122948008 | 12294800 | 3 | 20160706 | 0 |